Jordan Fein, MD
Pulmonary Disease · Portland, ORNPI 1255316345
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 83.8% of it on its own, with 16 other manufacturers making up the rest. Among pulmonary disease clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $793.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$73K
- AstraZeneca$3K
- Vapotherm Inc$2K
- Pulmonx Corporation$2K
- Paratek Pharmaceuticals, Inc.$1K
- Shire North American Group Inc$1K
- plus $4K from 11 others
Across 3 payments — averaging $1416.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gyrus ACMI, Inc.$4K
- Spiration, Inc.$750
What the payments were for
- Consulting fees$9,58511%
- Speaking & faculty fees$51,08559%
- Travel & lodging$11,42613%
- Food & beverage$3,2094%
- Education$12,00014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 81 | $73,193 |
| AstraZeneca | 2 | $2,630 |
| Vapotherm Inc | 6 | $2,380 |
| Pulmonx Corporation | 3 | $2,237 |
| Paratek Pharmaceuticals, Inc. | 1 | $1,360 |
| Shire North American Group Inc | 1 | $1,050 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $967 |
| ZOLL Medical Corporation | 2 | $753 |
| Johnson & Johnson | 3 | $728 |
| Smiths Medical ASD, Inc. | 1 | $487 |
| BD | 1 | $393 |
| Dr.reddy's Laboratories,inc. | 1 | $355 |
| ERBE USA Inc | 1 | $342 |
| Melinta Therapeutics, LLC | 1 | $180 |
| Cipla USA Inc. | 1 | $145 |
| Boston Scientific | 1 | $90 |
| Philips North America LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$60,021
- ION$12,000
- IMFINZI$2,630
- Precision Flow$2,284
- Pulmonx Endobronchial Valve EBV$2,153
- NUZYRA$1,360
- Monarch Platform$728
- Cryo2 VIO3$342
How this compares
$87,304 in reported general payments places this provider in the 95th percentile of 154 pulmonary disease providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $14,359 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,655 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Portland
- Stephen YauPortland$984K
- Matthew DrakePortland$135K
- Peter LeePortland$98K
- Granthem FarrPortland$66K
- David HotchkinPortland$65K
- Jeffrey RobinsonPortland$51K
- Steven SearsPortland$21K
- Melvin MorganrothPortland$14K
- Christina MacrostyPortland$13K
- Bishoy ZakharyPortland$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.